1. Home
  2. MPAA vs IKT Comparison

MPAA vs IKT Comparison

Compare MPAA & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Motorcar Parts  of America Inc.

MPAA

Motorcar Parts of America Inc.

HOLD

Current Price

$10.96

Market Cap

203.3M

ML Signal

HOLD

Logo Inhibikase Therapeutics Inc.

IKT

Inhibikase Therapeutics Inc.

HOLD

Current Price

$1.74

Market Cap

240.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPAA
IKT
Founded
1968
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
203.3M
240.1M
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
MPAA
IKT
Price
$10.96
$1.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$17.50
$5.00
AVG Volume (30 Days)
42.5K
830.6K
Earning Date
06-08-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
60.56
57.76
EPS
0.13
N/A
Revenue
$757,354,000.00
N/A
Revenue This Year
$1.50
N/A
Revenue Next Year
$7.42
N/A
P/E Ratio
$87.42
N/A
Revenue Growth
5.53
N/A
52 Week Low
$9.29
$1.33
52 Week High
$18.12
$2.26

Technical Indicators

Market Signals
Indicator
MPAA
IKT
Relative Strength Index (RSI) 44.55 40.45
Support Level $10.84 $1.62
Resistance Level $12.13 $1.74
Average True Range (ATR) 0.51 0.10
MACD -0.05 -0.02
Stochastic Oscillator 12.55 3.66

Price Performance

Historical Comparison
MPAA
IKT

About MPAA Motorcar Parts of America Inc.

Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard part in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

Share on Social Networks: